Redirected MazF-CD4 Autologous T Cells for HIV Gene Therapy

NCT01787994 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

GENETIC: Autologous CD4+ T cells genetically modified with a retroviral vector expressing the MazF endoribonuclease gene (MazF-T), given via intravenous infusion.

Sponsor

University of Pennsylvania